نسبة العدلات إلى اللمفاويات ومستويات الكوليسترول الكلي قبل العلاج كواسمات حيوية للتنبؤ بعدوانية سرطان الثدي

Kzar H.H., Al-Gazally M.E. and Wtwt M.A. Everolimus loaded NPs with FOL targeting: preparation, characterization and study of its cytotoxicity action on MCF-7 breast cancer cell lines. Jordan J. Pharm. Sci. 2022; 15(1):25–39. doi:10.35516/JJPS.V15I1.286. DOI: https://doi.org/10.35516/jjps.v15i1.286

Abu Msafer B.A., Abbas M.A., Al Shaer W. and Arafat S. Enhanced Platelet Activation Induced by Palbociclib Treatment in MCF-7 Breast Cancer Cells. Jordan J. Pharm. Sci. 2025; 18(1):10–20.

doi:10.35516/JJPS.V18I1.2459. DOI: https://doi.org/10.35516/jjps.v18i1.2459

Inasu M. and Lunds universitet. Cholesterol metabolism in breast cancer: Prognostic factors and optimizing treatment. [Online]. Accessed: Jul. 12, 2024; pp.14–59.

Smolarz B., Nowak A.Z. and Romanowicz H. Breast cancer—epidemiology, classification, pathogenesis and treatment (Review of literature). Cancers (Basel) 2022; 14(10). doi:10.3390/cancers14102569. DOI: https://doi.org/10.3390/cancers14102569

van ’t Veer L.J., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002; 415(6871):530–536. doi:10.1038/415530a. DOI: https://doi.org/10.1038/415530a

Manimaran D., Elangovan N. and Palanisamy V. Anti-tumorgenic impact of nano-formulated peptide HIF-Alpha therapy by DMBA induced mammary carcinoma in rodent type. Jordan J. Pharm. Sci. 2024; 17(4):783–793. doi:10.35516/jjps.v17i4.2482. DOI: https://doi.org/10.35516/jjps.v17i4.2482

Gonzalez H., Hagerling C. and Werb Z. Roles of the immune system in cancer: from tumor initiation to metastatic progression. Genes Dev. 2018; 32(19–20):1267–1284. doi:10.1101/gad.314617.118. DOI: https://doi.org/10.1101/gad.314617.118

Dirican A., et al. Do the derived neutrophil to lymphocyte ratio and the neutrophil to lymphocyte ratio predict prognosis in breast cancer? Int. J. Clin. Oncol. 2015; 20(1):70–81. doi:10.1007/s10147-014-0672-8. DOI: https://doi.org/10.1007/s10147-014-0672-8

Rayan N.A., Zaky A.H., Eltyb H.A., Zeidan A. and Zahran A.M. The prognostic significance of pre- and post-treatment neutrophil to lymphocyte ratio in breast cancer patients. J. Cancer Ther. 2019; 10(7):525–536. doi:10.4236/JCT.2019.107044. DOI: https://doi.org/10.4236/jct.2019.107044

Zhang H., Zhao W., Li X. and He Y. Cholesterol metabolism as a potential therapeutic target and a prognostic biomarker for cancer immunotherapy. Onco. Targets. Ther. 2021; 14:3803–3812.

doi:10.2147/OTT.S315998. DOI: https://doi.org/10.2147/OTT.S315998

Stadler S.C., Hacker U. and Burkhardt R. Cholesterol metabolism and breast cancer. Curr. Opin. Lipidol. 2016; 27(2):200–201. doi:10.1097/MOL.0000000000000285. DOI: https://doi.org/10.1097/MOL.0000000000000285

Nelson E.R., Chang C. and McDonnell D.P. Cholesterol and breast cancer pathophysiology. Trends Endocrinol. Metab. 2014; 25(12):649–655.

doi:10.1016/j.tem.2014.10.001. DOI: https://doi.org/10.1016/j.tem.2014.10.001

Gago-Dominguez M., et al. Neutrophil to lymphocyte ratio and breast cancer risk: analysis by subtype and potential interactions. Sci. Rep. 2020; 10(1):13203. doi:10.1038/s41598-020-70077-z. DOI: https://doi.org/10.1038/s41598-020-70077-z

Wiranata S., et al. Pretreatment neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as a stage determination in breast cancer. Open Access Maced. J. Med. Sci. 2020; 8(B):1058–1063.

doi:10.3889/OAMJMS.2020.5336. DOI: https://doi.org/10.3889/oamjms.2020.5336

American Joint Committee on Cancer. Breast. In: AJCC Cancer Staging Manual. 2017; p.589.

Philip A., Jose M., Jose W.M., Vijaykumar D.K. and Pavithran K. Pretreatment neutrophil-to-lymphocyte ratio predicts lymph node metastasis in triple-negative breast cancer. Indian J. Cancer 2022; 59(4):469–473. doi:10.4103/ijc.IJC_914_19. DOI: https://doi.org/10.4103/ijc.IJC_914_19

Gong Y.T., et al. Neutrophils as potential therapeutic targets for breast cancer. Pharmacol. Res. 2023; 198:106996. doi:10.1016/J.PHRS.2023.106996. DOI: https://doi.org/10.1016/j.phrs.2023.106996

Rana A.P.S., Kaur M., Zonunsanga B., Puri A. and Kuka A.S. Preoperative peripheral blood count in breast carcinoma: predictor of prognosis or a routine test. Int. J. Breast Cancer 2015; 2015:964392.

doi:10.1155/2015/964392. DOI: https://doi.org/10.1155/2015/964392

Okuturlar Y., et al. Utility of peripheral blood parameters in predicting breast cancer risk. Asian Pac. J. Cancer Prev. 2015; 16(6):2409–2412.

doi:10.7314/apjcp.2015.16.6.2409. DOI: https://doi.org/10.7314/APJCP.2015.16.6.2409

Gong W., Yang S., Yang X. and Guo F. Blood preoperative neutrophil-to-lymphocyte ratio is correlated with TNM stage in patients with papillary thyroid cancer. Clinics (Sao Paulo) 2016; 71(6):311–314.

doi:10.6061/clinics/2016(06)04. DOI: https://doi.org/10.6061/clinics/2016(06)04

Ozyalvacli G., Yesil C., Kargi E., Kizildag B., Kilitci A. and Yilmaz F. Diagnostic and prognostic importance of the neutrophil lymphocyte ratio in breast cancer. Asian Pac. J. Cancer Prev. 2014; 15(23):10363–10366. doi:10.7314/apjcp.2014.15.23.10363. DOI: https://doi.org/10.7314/APJCP.2014.15.23.10363

Fogar P., et al. Decreased total lymphocyte counts in pancreatic cancer: an index of adverse outcome. Pancreas 2006; 32(1):22–28.

doi:10.1097/01.mpa.0000188305.90290.50. DOI: https://doi.org/10.1097/01.mpa.0000188305.90290.50

Guthrie G.J.K., Charles K.A., Roxburgh C.S.D., Horgan P.G., McMillan D.C. and Clarke S.J. The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit. Rev. Oncol. Hematol. 2013; 88(1):218–230.

doi:10.1016/j.critrevonc.2013.03.010. DOI: https://doi.org/10.1016/j.critrevonc.2013.03.010

Halimi H. and Farjadian S. Cholesterol: an important actor on the cancer immune scene. Front. Immunol. 2022; 13:1057546. doi:10.3389/fimmu.2022.1057546. DOI: https://doi.org/10.3389/fimmu.2022.1057546

Ehmsen S., et al. Increased cholesterol biosynthesis is a key characteristic of breast cancer stem cells influencing patient outcome. Cell Rep. 2019; 27(13):3927–3938.e6. doi:10.1016/j.celrep.2019.05.104. DOI: https://doi.org/10.1016/j.celrep.2019.05.104

Sökmen F.C. and Karacin C. The role of peripheral blood inflammatory markers in the staging of breast cancer. East J. Med. 2021; 26(1):171–174.

doi:10.5505/ejm.2021.71542. DOI: https://doi.org/10.5505/ejm.2021.71542

Elyasinia F., et al. Neutrophil-lymphocyte ratio in different stages of breast cancer. Acta Med. Iran. 2017; 55(4):228–232. Available:

http://www.ncbi.nlm.nih.gov/pubmed/28532133

Anwar S.L., Cahyono R., Avanti W.S., Budiman H.Y., Harahap W.A. and Aryandono T. Pre-treatment neutrophil-lymphocyte and platelet-lymphocyte ratios as additional markers for breast cancer progression: a retrospective cohort study. Ann. Med. Surg. 2021; 63:102144. doi:10.1016/j.amsu.2021.01.092. DOI: https://doi.org/10.1016/j.amsu.2021.01.092

Ahmad S.S., Ashraf S., Jamal A. and Akhtar K. Total serum cholesterol level in cases of carcinoma breast—a correlative study. [Online]. Accessed: Mar. 02, 2024. Available: www.sospublication.co.in

Jin W., et al. The correlation between blood lipids and clinicopathological features of breast cancer in young females. Gland Surg. 2020; 9(5):1443–1449.

doi:10.21037/gs-20-616. DOI: https://doi.org/10.21037/gs-20-616

Ben Hassen C., et al. Is cholesterol a risk factor for breast cancer incidence and outcome? J. Steroid Biochem. Mol. Biol. 2023; 232:106346.

doi:10.1016/j.jsbmb.2023.106346. DOI: https://doi.org/10.1016/j.jsbmb.2023.106346

García-Estévez L., Cortés J., Pérez S., Calvo I., Gallegos I. and Moreno-Bueno G. Obesity and breast cancer: a paradoxical and controversial relationship influenced by menopausal status. Front. Oncol. 2021; 11:705911. doi:10.3389/fonc.2021.705911. DOI: https://doi.org/10.3389/fonc.2021.705911

Feng X., et al. Expression of EMT markers and mode of surgery are prognostic in phyllodes tumors of the breast. Oncotarget 2017; 8(20):33365–33374.

doi:10.18632/oncotarget.16497. DOI: https://doi.org/10.18632/oncotarget.16497

Owiredu W.K.B.A., Donkor S., Addai B.W. and Amidu N. Serum lipid profile of breast cancer patients. Pakistan J. Biol. Sci. 2009; 12(4):332–338.

doi:10.3923/pjbs.2009.332.338. DOI: https://doi.org/10.3923/pjbs.2009.332.338

Ha M., Sung J. and Song Y.-M. Serum total cholesterol and the risk of breast cancer in postmenopausal Korean women. Cancer Causes Control 2009; 20(7):1055–1060. doi:10.1007/s10552-009-9301-7. DOI: https://doi.org/10.1007/s10552-009-9301-7

Mc Auley M.T. Effects of obesity on cholesterol metabolism and its implications for healthy ageing. Nutr. Res. Rev. 2020; 33(1):121–133.

doi:10.1017/S0954422419000258. DOI: https://doi.org/10.1017/S0954422419000258

Zipinotti Dos Santos D., et al. The impact of lipid metabolism on breast cancer: a review about its role in tumorigenesis and immune escape. Cell Commun. Signal. 2023; 21(1):161. doi:10.1186/s12964-023-01178-1. DOI: https://doi.org/10.1186/s12964-023-01178-1